Circulating protein and antibody biomarker for personalized cancer immunotherapy

Immune checkpoint blockade therapies are revolutionizing standard cancer treatments. Immune checkpoint inhibitors likely function to enhance the tumor specific antigen response in order to achieve favorable clinical outcomes. Thus, continuous efforts to identify the common tumor-specific antigens ar...

Descripción completa

Detalles Bibliográficos
Autor principal: Yuan, Jianda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986378/
https://www.ncbi.nlm.nih.gov/pubmed/27532021
http://dx.doi.org/10.1186/s40425-016-0150-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986378/
https://www.ncbi.nlm.nih.gov/pubmed/27532021
http://dx.doi.org/10.1186/s40425-016-0150-0

Ejemplares similares